The La Jolla-based research institute continues its founding principle of collaboration across multiple fields ...

Researchers at the Weill Institute for Cell and Molecular Biology have uncovered new evidence that two major types of gene-controlling DNA sequences, promoters and enhancers, operate with a shared ...

The FDA cleared a second arm for enrollment in the trial after one NSCLC patient demonstrated a complete response to the non-boosted therapy.

As of Friday, February 27, ImmunityBio, Inc.’s IBRX share price has dipped by 7.02%, which has investors questioning if this is right time to buy.

Advancing Research, Awareness, and Targeted Youth Advocacy for Women Diagnosed with Breast Cancer Before Age 40 DENVER, ...

The trials in breast, lung, and colorectal cancer, supported by ARPA-H, will focus on guiding decisions across different lines of therapy using serial biopsies and tumor profiling.

The field of cancer genetics and oncogenomics is undergoing a transformative shift as multi-omics approaches become central to understanding the complex ...

Tidewave Bio, a biotechnology company developing a universal, biopsy-native immunotherapy platform for solid tumors, today announced the appointment of Prof. Alexander M.M. Eggermont, MD, PhD, as Head ...

The emerging field of Cancer Neuroscience has revealed that the nervous system plays a pivotal role in cancer initiation, progression, and metastasis.

Irish and American researchers have identified a potential new way to counter treatment‑resistant prostate cancer by ...

Generate:Biomedicines is the latest biotech to benefit from a renewed appetite from investors for publicly listed drug developers. | Generate:Biomedicines is the latest biotech to benefit from a ...

TruPath™ Genome offers more complete genome, with the simplest sample to sequencer workflow, and the new AGBT data demonstrates ...